Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 12:18:2387-2399.
doi: 10.2147/RMHP.S524872. eCollection 2025.

Association Between Weight-Adjusted Waist Circumference Index and Metabolic Disease-Associated Fatty Liver Disease: A Retrospective Study

Affiliations

Association Between Weight-Adjusted Waist Circumference Index and Metabolic Disease-Associated Fatty Liver Disease: A Retrospective Study

Ting Tang et al. Risk Manag Healthc Policy. .

Abstract

Background: Metabolic disease-associated fatty liver disease has brought significant challenges to public health and social-economics. There is a need for a straightforward and effective method to screen for metabolic disease-associated fatty liver disease. The weight-adjusted waist circumference index offers a comprehensive reflection of visceral fat accumulation and skeletal muscle loss. This study aims to explore the relationship between weight-adjusted waist circumference index and hepatic steatosis and hepatic fibrosis.

Methods: This single-centered study screened 288 participants from the outpatient department of the Affiliated Hospital of Hangzhou Normal University (Hangzhou, China). Multiple linear regression models were utilized to assess the association between weight-adjusted waist circumference index and hepatic steatosis and hepatic fibrosis. The subgroup analysis was carried out according to sex, smoking, drinking, BMI, cardiovascular disease, diabetes and hypertension.

Results: Metabolic disease-associated fatty liver disease was diagnosed in 185 out of 288 patients. Multivariate linear regression analysis indicated a positive linear correlation between weight-adjusted waist circumference index and hepatic steatosis and hepatic fibrosis (P < 0.05). Analysis of subgroups revealed a stronger positive correlation between weight-adjusted waist circumference index and controlled attenuation parameter among participants aged 18-59 years and smokers (P < 0.05). Positive correlations between weight-adjusted waist circumference index and hepatic fibrosis were observed in participants who were alcohol consumers, male, had a body mass index of >28, and with diabetes (P < 0.05).

Conclusion: We report a significant linear positive correlation between weight-adjusted waist circumference index and metabolic disease-associated fatty liver disease, suggesting that weight-adjusted waist circumference index is a potential indicator for metabolic disease-associated fatty liver disease screening.

Keywords: abdominal obesity; cross-sectional study; hepatic fibrosis; hepatic steatosis; metabolic-associated fatty liver disease; weight-adjusted waist index.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests in this work.

Figures

Figure 1
Figure 1
Flowchart of the sample selection from outpatient patients at the Affiliated Hospital of Hangzhou Normal University.
Figure 2
Figure 2
Subgroup analysis for the association between WWI and hepatic steatosis.
Figure 3
Figure 3
Subgroup analysis for the association between WWI and hepatic fibrosis.

References

    1. Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11–20. doi: 10.1038/nrgastro.2017.109 - DOI - PubMed
    1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73. doi: 10.1002/hep.28431 - DOI - PubMed
    1. Xiao J, Wang F, Wong N-K, et al. Global liver disease burdens and research trends: analysis from a Chinese perspective. J Hepatol. 2019;71:212–221. doi: 10.1016/j.jhep.2019.03.004 - DOI - PubMed
    1. Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism. 2019;92:82–97. doi: 10.1016/j.metabol.2018.11.014 - DOI - PubMed
    1. Brunt EM, Wong VW-S, Nobili V, et al. Nonalcoholic fatty liver disease. Nat Rev Dis Primers. 2015;1:15080. doi: 10.1038/nrdp.2015.80 - DOI - PubMed

LinkOut - more resources